Northern Trust’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.04M | Buy |
240,968
+11,079
| +5% | +$149K | ﹤0.01% | 2735 |
|
|
2025
Q4 | $3.63M | Buy |
229,889
+33,993
| +17% | +$432K | ﹤0.01% | 2661 |
|
|
2025
Q3 | $2.34M | Sell |
195,896
-55,318
| -22% | -$442K | ﹤0.01% | 2941 |
|
|
2025
Q2 | $1.9M | Sell |
251,214
-69,298
| -22% | -$417K | ﹤0.01% | 3017 |
|
|
2025
Q1 | $1.77M | Sell |
320,512
-66,864
| -17% | -$413K | ﹤0.01% | 2987 |
|
|
2024
Q4 | $2.23M | Sell |
387,376
-149,329
| -28% | -$1.43M | ﹤0.01% | 2964 |
|
|
2024
Q3 | $5.56M | Sell |
536,705
-308,411
| -36% | -$4.03M | ﹤0.01% | 2412 |
|
|
2024
Q2 | $11M | Sell |
845,116
-88,240
| -9% | -$1.19M | ﹤0.01% | 1941 |
|
|
2024
Q1 | $16.3M | Sell |
933,356
-2,137
| -0.2% | -$28.3K | ﹤0.01% | 1726 |
|
|
2023
Q4 | $8.8M | Sell |
935,493
-24,413
| -3% | -$227K | ﹤0.01% | 2153 |
|
|
2023
Q3 | $10.7M | Sell |
959,906
-14,871
| -2% | -$240K | ﹤0.01% | 1956 |
|
|
2023
Q2 | $20.9M | Buy |
974,777
+111,461
| +13% | +$3.29M | ﹤0.01% | 1558 |
|
|
2023
Q1 | $34.9M | Sell |
863,316
-19,814
| -2% | -$946K | 0.01% | 1186 |
|
|
2022
Q4 | $41.1M | Sell |
883,130
-81,277
| -8% | -$3.71M | 0.01% | 1047 |
|
|
2022
Q3 | $50M | Buy |
964,407
+33,116
| +4% | +$1.93M | 0.01% | 857 |
|
|
2022
Q2 | $44M | Buy |
931,291
+3,198
| +0.3% | +$174K | 0.01% | 957 |
|
|
2022
Q1 | $66.1M | Sell |
928,093
-84,071
| -8% | -$5.47M | 0.01% | 842 |
|
|
2021
Q4 | $75.7M | Buy |
1,012,164
+53,116
| +6% | +$4.17M | 0.01% | 810 |
|
|
2021
Q3 | $54.5M | Buy |
959,048
+310,246
| +48% | +$15.3M | 0.01% | 1013 |
|
|
2021
Q2 | $28.6M | Buy |
648,802
+3,888
| +0.6% | +$190K | 0.01% | 1632 |
|
|
2021
Q1 | $31.8M | Buy |
644,914
+407,185
| +171% | +$20.3M | 0.01% | 1489 |
|
|
2020
Q4 | $10M | Sell |
237,729
-10,312
| -4% | -$454K | ﹤0.01% | 2247 |
|
|
2020
Q3 | $11.4M | Sell |
248,041
-6,619
| -3% | -$321K | ﹤0.01% | 2042 |
|
|
2020
Q2 | $12.8M | Sell |
254,660
-3,906
| -2% | -$202K | ﹤0.01% | 1951 |
|
|
2020
Q1 | $13.3M | Buy |
258,566
+24,268
| +10% | +$1.29M | ﹤0.01% | 1697 |
|
|
2019
Q4 | $14.5M | Sell |
234,298
-7,349
| -3% | -$456K | ﹤0.01% | 1945 |
|
|
2019
Q3 | $14.5M | Buy |
241,647
+7,610
| +3% | +$565K | ﹤0.01% | 1910 |
|
|
2019
Q2 | $19.7M | Buy |
234,037
+2,657
| +1% | +$239K | ﹤0.01% | 1704 |
|
|
2019
Q1 | $22.1M | Sell |
231,380
-9,423
| -4% | -$845K | 0.01% | 1604 |
|
|
2018
Q4 | $17.1M | Buy |
240,803
+9,207
| +4% | +$706K | ﹤0.01% | 1705 |
|
|
2018
Q3 | $19.8M | Buy |
231,596
+7,653
| +3% | +$767K | ﹤0.01% | 1808 |
|
|
2018
Q2 | $26M | Buy |
223,943
+32,113
| +17% | +$3.2M | 0.01% | 1562 |
|
|
2018
Q1 | $15.5M | Sell |
191,830
-8,527
| -4% | -$656K | ﹤0.01% | 1882 |
|
|
2017
Q4 | $11.8M | Buy |
200,357
+4,834
| +2% | +$242K | ﹤0.01% | 2081 |
|
|
2017
Q3 | $9.15M | Sell |
195,523
-189
| -0.1% | -$7.6K | ﹤0.01% | 2257 |
|
|
2017
Q2 | $7.04M | Buy |
195,712
+7,772
| +4% | +$249K | ﹤0.01% | 2403 |
|
|
2017
Q1 | $5.79M | Sell |
187,940
-2,371
| -1% | -$73.8K | ﹤0.01% | 2463 |
|
|
2016
Q4 | $6.38M | Buy |
190,311
+7,494
| +4% | +$215K | ﹤0.01% | 2386 |
|
|
2016
Q3 | $4.86M | Buy |
182,817
+5,770
| +3% | +$134K | ﹤0.01% | 2539 |
|
|
2016
Q2 | $3.9M | Sell |
177,047
-9,326
| -5% | -$244K | ﹤0.01% | 2630 |
|
|
2016
Q1 | $5.47M | Buy |
186,373
+5,104
| +3% | +$142K | ﹤0.01% | 2354 |
|
|
2015
Q4 | $5.99M | Buy |
181,269
+4,110
| +2% | +$134K | ﹤0.01% | 2356 |
|
|
2015
Q3 | $6.4M | Buy |
177,159
+47,120
| +36% | +$2.02M | ﹤0.01% | 2296 |
|
|
2015
Q2 | $5.85M | Buy |
130,039
+9,363
| +8% | +$364K | ﹤0.01% | 2424 |
|
|
2015
Q1 | $3.7M | Buy |
120,676
+143
| +0.1% | +$5.56K | ﹤0.01% | 2701 |
|
|
2014
Q4 | $6.13M | Sell |
120,533
-789
| -0.7% | -$35.3K | ﹤0.01% | 2370 |
|
|
2014
Q3 | $4.8M | Buy |
121,322
+64,879
| +115% | +$2.59M | ﹤0.01% | 2534 |
|
|
2014
Q2 | $2.43M | Buy |
56,443
+5,204
| +10% | +$199K | ﹤0.01% | 2975 |
|
|
2014
Q1 | $2.05M | Sell |
51,239
-2,274
| -4% | -$82.6K | ﹤0.01% | 3124 |
|
|
2013
Q4 | $1.46M | Buy |
53,513
+3,977
| +8% | +$96.4K | ﹤0.01% | 3276 |
|
|
2013
Q3 | $1.14M | Buy |
49,536
+36,138
| +270% | +$691K | ﹤0.01% | 3302 |
|
|
2013
Q2 | $237K | Buy |
+13,398
| New | +$261K | ﹤0.01% | 3626 |
|
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Northern Trust's ENTA Position: Q1 2026 in Review
Northern Trust increased its Enanta Pharmaceuticals (ENTA) stake by 4.8% in Q1 2026, buying an estimated $149K and bringing the position to 240,968 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2735.
Northern Trust first reported a position in ENTA in Q2 2013 and has held it in 52 quarters since. The position peaked at $75.7M in Q4 2021. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Northern Trust held 240,968 shares of Enanta Pharmaceuticals worth $3.04M as of Q1 2026.
- Northern Trust bought 11,079 Enanta Pharmaceuticals shares in Q1 2026, an estimated $149K.
- Enanta Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2735 holding.
- Northern Trust first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Enanta Pharmaceuticals position peaked at $75.7M in Q4 2021.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.